Luo Q - Search Results

1

STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity.

Pei J, Zhang Y, Luo Q, Zheng W, Li W, Zeng X, Li Q, Quan J. Pei J, et al. Among authors: luo q. Cancer Lett. 2019 May 28;450:110-122. doi: 10.1016/j.canlet.2019.02.029. Epub 2019 Feb 18. Cancer Lett. 2019. PMID: 30790684 Free article.

2

Identification of α-Mangostin as an Agonist of Human STING.

Zhang Y, Sun Z, Pei J, Luo Q, Zeng X, Li Q, Yang Z, Quan J. Zhang Y, et al. Among authors: luo q. ChemMedChem. 2018 Oct 8;13(19):2057-2064. doi: 10.1002/cmdc.201800481. Epub 2018 Aug 30. ChemMedChem. 2018. PMID: 30079976

3

S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.

Xie Z, Lu L, Wang Z, Luo Q, Yang Y, Fang T, Chen Z, Ma D, Quan J, Xi Z. Xie Z, et al. Among authors: luo q. Eur J Med Chem. 2022 Dec 5;243:114796. doi: 10.1016/j.ejmech.2022.114796. Epub 2022 Sep 28. Eur J Med Chem. 2022. PMID: 36198216

4

Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation.

Wang X, Wang Y, Cao A, Luo Q, Chen D, Zhao W, Xu J, Li Q, Bu X, Quan J. Wang X, et al. Among authors: luo q. Nat Commun. 2023 Oct 2;14(1):6132. doi: 10.1038/s41467-023-41892-5. Nat Commun. 2023. PMID: 37783727 Free PMC article.

5

Diversity-Oriented Synthesis of ERα Modulators via Mitsunobu Macrocyclization.

Dai C, Lian C, Fang H, Luo Q, Huang J, Yang M, Yang H, Zhu L, Zhang J, Yin F, Li Z. Dai C, et al. Among authors: luo q. Org Lett. 2022 May 20;24(19):3532-3537. doi: 10.1021/acs.orglett.2c01239. Epub 2022 May 12. Org Lett. 2022. PMID: 35546524

6

Covalent Peptide LSD1 Inhibitor Specifically Recognizes Cys360 in the Enzyme-Active Region.

Luo Q, Ma Y, Liang H, Feng Y, Liu N, Lian C, Zhu L, Ye Y, Liu Z, Hou Z, Chen S, Wang Y, Dai C, Song C, Zhang M, He Z, Xing Y, Zhong W, Li S, Wu J, Lu F, Yin F, Li Z. Luo Q, et al. J Med Chem. 2023 Nov 23;66(22):15409-15423. doi: 10.1021/acs.jmedchem.3c01549. Epub 2023 Nov 3. J Med Chem. 2023. PMID: 37922441

7

Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach.

Song C, Jiao Z, Hou Z, Wang R, Lian C, Xing Y, Luo Q, An Y, Yang F, Wang Y, Sha X, Ruan Z, Ye Y, Liu Z, Li Z, Yin F. Song C, et al. Among authors: luo q. J Am Chem Soc. 2023 Oct 11;145(40):21860-21870. doi: 10.1021/jacs.3c05948. Epub 2023 Sep 14. J Am Chem Soc. 2023. PMID: 37708462

8

Covalent PROTAC design method based on a sulfonyl pyridone probe.

Luo Q, Wang Y, Hou Z, Liang H, Tu L, Xing Y, Wan C, Liu J, Wang R, Zhu L, Han W, Wu J, Lu F, Yin F, Li Z. Luo Q, et al. Chem Commun (Camb). 2024 Jan 16;60(6):686-689. doi: 10.1039/d3cc05127g. Chem Commun (Camb). 2024. PMID: 38054347

9

A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy.

Wang J, Wang Y, Yang F, Luo Q, Hou Z, Xing Y, Lu F, Li Z, Yin F. Wang J, et al. Among authors: luo q. ACS Chem Biol. 2024 Apr 25. doi: 10.1021/acschembio.4c00092. Online ahead of print. ACS Chem Biol. 2024. PMID: 38662199

10

Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach.

Yang F, Luo Q, Wang Y, Liang H, Wang Y, Hou Z, Wan C, Wang Y, Liu Z, Ye Y, Zhu L, Wu J, Yin F, Li Z. Yang F, et al. Among authors: luo q. J Am Chem Soc. 2023 Apr 12;145(14):7879-7887. doi: 10.1021/jacs.2c12824. Epub 2023 Mar 31. J Am Chem Soc. 2023. PMID: 37001133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,647 results

Search Page